Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
4 of 6 columns
Comparison
| Attribute | ASCENDIA PHARMACEUTICALS, INC.5.3remove | Ellipsys Medical, Inc.5.3remove | Gradient Health, Inc.5.2remove | NOVIR, INC.5.2remove |
|---|---|---|---|---|
| Signal scores | ||||
| Radar composite | 5.3 | 5.3 | 5.2 | 5.2 |
| IPO signal score | 10.5 | 10.5 | 10.4 | 10.4 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE0.0 | ACCELERATING+7.6 | STABLE+3.2 | STABLE+3.2 |
| Company | ||||
| Stage | private | private | private | private |
| Sector | Health Care | Health Care | Health Care | Health Care |
| Headquarters | NORTH BRUNSWICK, United States | SAN CLEMENTE, United States | DURHAM, United States | MILWAUKEE, United States |
| Founded | not on record | 2026 | not on record | not on record |
| Employees | not on record | not on record | not on record | not on record |
| Capital | ||||
| Latest valuation | not on record | not on record | not on record | not on record |
| Total funding | $4M | $4M | $3M | $3M |
| Latest round | Private Placement $4M | Private Placement $4M | Private Placement $3M | Private Placement $3M |
| Investors on record | 0 | 0 | 0 | 0 |
| Evidence | ||||
| Institutional relationships | 0 | 0 | 0 | 0 |
| Active signals | 1 | 1 | 1 | 1 |
| Confidence | 53% | 54% | 53% | 53% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.